Top

Published in:

01-06-2014 | Review Article

Differential Diagnosis of White Matter Lesions: Nonvascular Causes—Part II

Authors: S. Weidauer, M. Nichtweiß, E. Hattingen

Published in: Clinical Neuroradiology | Issue 2/2014

Abstract

The knowledge of characteristic lesion patterns is important in daily practice imaging, as the radiologist increasingly is required to provide precise differential diagnosis despite unspecific clinical symptoms like cognitive impairment and missed elaborated neurological workup. This part II dealing with nonvascular white matter changes of proven cause and diagnostic significance aimed to assist the evaluation of diseases exhibiting lesions exclusively or predominantly located in the white matter. The etiologies commented on are classified as follows: (a) toxic–metabolic, (b) leukodystrophies and mitochondriopathies, (c) infectious, (d) neoplastic, and (e) immune mediated. The respective mode of lesion formation is characterized, and typical radiological findings are displayed. More or less symmetrical lesion patterns on the one hand as well as focal and multifocal ones on the other are to be analyzed with reference to clinical data and knowledge of predilection sites characterizing major disease categories. Complementing spinal cord imaging may be useful not only in acute and relapsing demyelinating diseases but in certain leukodystrophies as well. In neuromyelitis optica (NMO), the detection of a specific antibody and some recently published observations may lead to a new understanding of certain deep white matter lesions occasionally complicating systemic autoimmune disease.

Schmahmann JD, Smith EE, Eichler FS, Filley CM. Cerebral white matter neuroanatomy, clinical neurology and neurobehavioral correlates. Ann NY Acad Sci. 2008;1142:266–309.PubMedCentralPubMed

Vitali P, Migliaccio R, Agosta F, Rosen HJ, Geschwind MD. Neuroimaging in Dementia. Semin Neurol. 2008;28:467–83.PubMedCentralPubMed

Valk J, Barkhof F, Scheltens P. Magnetic Resonance in Dementia. Berlin: Springer; 2003 (Chapter 4.3).

Vernino S, Geschwind M, Boeve B. Autoimmune encephalopathies. Neurologist. 2007;13:140–7.PubMed

Nichtweiß M, Weidauer S, Treusch N, Hattingen E. White matter lesions and vascular cognitive impairment Part I: typical and unusual causes. Clin Neuroradiol. 2012;22:193–210.PubMed

Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med. 2001;345:425–32.PubMed

Arora A, Neema M, Stankiewicz J, Guss ZD, Guss JG, Prockop L, et al. Neuroimaging of Toxic and Metabolic Disorders. Semin Neurol. 2008;28:495–510.PubMed

Barkhof F, Fox NC, Bastos-Leite AJ, Scheltens P. Neuroimaging in Dementia. Berlin: Springer; 2011.

Blasel S, Hattingen E, Adelmann M, Nichtweiß M, Zanella FE, Weidauer S. Toxic leukoencephalopathy after heroin abuse without heroin vapour inhalation: MR imaging and clinical features in 3 patients. Clin Neuroradiol. 2010;20:48–53.PubMed

10.

Kleinschmidt-Demasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science. 1981;211:1068–70.PubMed

11.

Ruzek KA, Campeau NG, Miller GM. Early diagnosis of central pontine myelinolysis with diffusion-weighted imaging. AJNR Am J Neuroradiol. 2004;25:210–3.PubMed

12.

Gocht A, Colmant HJ. Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol. 1987;6:262–70.PubMed

13.

McNamee T, Forsythe S, Wollmann R, Ndwukwu M. Central pontine myelinolysis in a patient with classic heat stroke. Arch Neurol 1997;54:935–6.PubMed

14.

Ashrafian H, Davey P. A review of the causes of central pontine myelinolysis: yet another apoptotic illness? Eur J Neurol. 2001;8:103–9.PubMed

15.

DeLuca GC, Esiri MM, Davey P. Evidence for a role for apoptosis in central pontine myelinolysis. Acta Neuropathol. 2002;103:590–8.PubMed

16.

Raina S, Mahesh DM, Mahajan J, Kaushal SS, Gupta D, Dhiman DS. Marchiafava–Bignami Disease. J Assoc Physicians India. 2008;56:633–5.PubMed

17.

Ménégon P, Sibon I, Pachai C, Orgogozo JM, Dousset V. Marchiafava–Bignami disease: diffusion-weighted MRI in corpus callosum and cortical lesions. Neurology. 2005;65:475–7.PubMed

18.

Heinrich A, Runge U, Khaw AV. Clinicoradiologic subtypes of Marchiafava–Bignami disease. J Neurol. 2004;251:1050–9.PubMed

19.

Gürtler S, Ebner A, Tuxhorn I, Ollech I, Pohlmann-Eden B, Woermann FG. Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal. Neurology. 2005;65:1032–6.PubMed

20.

Hattingen E, Raab P, Lanfermann H, Zanella FE, Weidauer S. Postictal MR changes. A rare and important differential diagnosis. Radiologe. 2008;48:1058–65.PubMed

21.

Vry MS, Haerter K, Kastrup O, Gizewski E, Frings M, Maschke M. Vitamine-B12-deficiency causing isolated and partially reversible leukoencephalopathy. J Neurol. 2005;252:980–2.PubMed

22.

Stojsavljevic N, Levic Z, Drulovic J, Dragutinovic G. A 44-month clinical- brain MRI follow-up in a patient with B12 deficiency. Neurology. 1997;49:878–81.PubMed

23.

Kumar N, Gross JB Jr, Ahlskog JE. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology. 2004;63:33–9.PubMed

24.

Prodan CI, Holland NR, Wisdom PJ, Burstein SA, Bottomley SS. CNS demyelination associated with copper deficiency and hyperzincemia. Neurology. 2002;59:1453–6.PubMed

25.

Hathout L, El-Saden S. Nitrous oxide-induced B 12 deficiency myelopathy: Perspectives on the clinical biochemistry of vitamin B 12. J Neurol Sci. 2011;301:1–8.PubMed

26.

Kang SY, Kang JH, Choi JC, Lee JS. Posterior reversible encephalopathy syndrome in a patient with acute intermittent porphyria. J Neurol. 2010;257:663–4.PubMed

27.

Maramattom BV, Zaldivar RA, Glynn SM, Eggers SD, Wijdicks EF. Acute intermittent porphyria presenting as a diffuse encephalopathy. Ann Neurol. 2005;57:581–4.PubMed

28.

Weidauer S, Gaa J, Neumann-Haefelin T, Lanfermann H, Zanella FE. Posterior encephalopathy: Neuroradiological findings, etiology and clinical course. Clin Neuroradiol. 2003;13:34–44.

29.

Weidauer S, Gaa J, Sitzer M, Hefner R, Lanfermann H, Zanella FE. Posterior encephalopathy syndrome associated with vasospasm: MR imaging and DSA findings. Neuroradiology. 2003;45:869–76.PubMed

30.

Bylesjö I, Brekke OL, Prytz J, Skjeflo T, Salvesen R. brain magnetic resonance imaging white matter lesions and cerebrospinal fluid findings in patients with acute intermittent porphyria. Eur Neurol. 2004;51:1–5.PubMed

31.

Rovira A, Alonso J, Córdoba J. MR imaging findings in hepatic encephalopathy. Am J Neuroradiol. 2008;29:1612–21.PubMed

32.

Costello DJ, Eichler AF, Eichler FS. Leucodystrophies: classification, diagnosis and treatment. Neurologist. 2009;15:319–28.PubMed

33.

Schiffmann R, van der Knaap MS. An MRI-based approach to the diagnosis of white matter disorders. Neurology. 2009;72:750–9.PubMedCentralPubMed

34.

Kohlschütter A, Bley A, Brockmann K, Gärtner J, Krägeloh-Mann I, Rolfs A, et al. Leukodystrophies and other genetic metabolic leukoencephalopathies in children and adults. Brain Dev. 2010;32:82–9.PubMed

35.

van der Knaap MS, Valk J. Magnetic resonance of myelination, and myelin disorders. Berlin: Springer; 2005.

36.

Keegan BM, Giannini C, Parisi JE, Lucchinetti CF, Boeve BF, Josephs KA. Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS. Neurology. 2008;70:1128–33.PubMed

37.

Kelley BJ, Boeve BF, Josephs KA. Young-onset dementia: Demographic and etiologic characteristics of 235 patients. Arch Neurol. 2008;65:1502–8.PubMed

38.

Bugiani M, Boor I, Powers JM, Scheper GC, van der Knaap MS. Leukoencephalopathy with vanishing white matter: a review J Neuropathol Exp Neurol. 2010;987–96.

39.

Lerman-Sagie T, Leshinsky-Silver E, Watemberg N, Luckman Y, Lev D. White matter involvement in mitochondrial diseases. Mol Genet Metab. 2005;84:127–36.PubMed

40.

Hattingen E, Blasel S, Nichtweiss M, Zanella FE, Weidauer S. MR imaging of midbrain pathologies. Clin Neuroradiol. 2010;20:81–97.PubMed

41.

Farina L, Pareyson D, Minati L, Ceccherini I, Chiapparini L, Romano S, et al. Can MR imaging diagnose adult-onset Alexander disease? Am J Neuroradiol. 2008;29:1190–6.PubMed

42.

van der Knaap M, van der Voorn P, Feigenbaum A, et al. A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate. Ann Neurol. 2003;53:252–8.PubMed

43.

Van der Lei HD, Steeenweg ME, Barkhof F, et al. Restricted diffusion in vanishing white matter. Arch Neurol. 2012;69:723–7.PubMed

44.

Ding XQ, Bley A, Ohlenbusch A, Kohlschütter A, Fiehler J, Zhu W, et al. Imaging evidence of early brain tissue degeneration in patients with vanishing white matter disease: a multimodal MR study. J Magn Reson Imaging. 2012;35:926–32.PubMed

45.

Labauge P, Dorboz I, Eymard-Pierre E Dereeper O, Boespflug-Tanguy O: Clinically asymptomatic adult patient with extensive LBSL MRI pattern and DARS2 mutations. J Neurol. 2011;258:335–7.PubMed

46.

Steenweg ME, van Berge L, van Berkel CG, de Coo IF, Temple IK, Brockmann K, et al: Early-onset LBSL: How severe does it get? Neuropediatrics. 2012;43:332–8.PubMed

47.

Online Mendelian Inheritance in Man (OMIM). http://www.ncbi.nim.nih.gov/omim.

48.

Scaravilli F, Bazille C, Gray F. Neuropathologic contributions to understanding AIDS and the central nervous system. Brain Pathol. 2007;17:197–208.PubMed

49.

Smith AB, Smirniotopoulos J, Rushing EJ. From the archives of the AFIP central nervous system infections associated with human immunodeficiency virus infection: radiologic—pathologic correlation. RadioGraphics. 2008;28:2033–58.PubMed

50.

Shah R, Bag AK, Chapman PR, Curé JK. Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol. 2010;65:431–9.PubMed

51.

Gray F, Bazille C, Adle-Biassette H, Mikol J, Moulignier A, Scaravilli F. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol. 2005;11 suppl 3:16–22.

52.

Koralnik IJ. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol. 2006;60:162–73.PubMed

53.

Nichtweiß M, Madlener J, Lang C, Enzensberger W, Hacker H. Charakteristika der progressiven multifokalen Leukenzephalopathie (PML). Clin Neuroradiol. 1994;4:185–95.

54.

Yousry TA, Major EO, Ryschkewitsch C, Fahle G, Fischer S, Hou J, et al. Evaluation of patients treated with Natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med. 2006;354:924–33.PubMedCentralPubMed

55.

Huang D, Cossoy M, Li M, Choi D, Taege A, Staugaitis SM, et al. Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients. Ann Neurol. 2007;62:34–9.PubMed

56.

Bulakbasi N, Kocaoglu M. Central nervous system infections of herpesvirus family. Neuroimaging Clin N Am. 2008;18:53–83.PubMed

57.

Kastrup O, Wanke I, Maschke M. Neuroimaging of infections of the central nervous system. Semin Neurol. 2008;28:511–22.PubMed

58.

Provenzale JM, van Landingham K, White LE. Clinical and imaging findings suggesting human herpesvirus 6 encephalitis. Pediatr Neurol. 2010;42:32–9.PubMed

59.

Sharma RR. Fungal infections of the nervous system: current perspective and controversies in management. Int J Surg. 2010;8:591–601.

60.

Dubey A, Patwardhan RV, Sampath S, Santosh V, Kolluri S, Nanda A. Intracranial fungal granuloma: analysis of 40 patients and review of the literature. Surg Neurol. 2005;63:254–60.PubMed

61.

Saigal G, Post MJD, Lolayekar S, Murtaza A. Unusual presentation of central nervous system cryptococcal infection in an immunocompetent patient. AJNR Am J Neuroradiol. 2005;26:2522–6.PubMed

62.

Gaviani P, Schwartz RB, Hedley-Whyte T, Ligon KL, Robicsek A, Schaefer P, et al. Diffusion-weighted imaging of fungal cerebral infection. Am J Neuroradiol. 2005;26:1115–21.PubMed

63.

Mohamed W, Neil E, Kupsky WJ, Juhász C, Mittal S, Santhakumar S. Isolated intracranial Whipple’s disease–report of a rare case and review of the literature. J Neurol Sci. 2011;308:1–8.PubMed

64.

Kremer S, Besson G, Bonaz B, Pasquier B, Le Bas JF, Grand S. Diffuse lesions in CNS revealed by MR Imaging in a case of Whipple disease. Am J Neuroradiol. 2001;22.493–5.PubMed

65.

Black DF, Aksamit AJ, Morris MJ. MR imaging of central nervous system Whipple disease: a 15-year review. Am J Neuroradiol. 2010;31:1493–7.PubMed

66.

Nagappa M, Sinha S, Taly AB, Rao SL, Nagarathna S, Bindu PS, et al. Neurosyphilis: MRI features and their phenotypic correlation in a cohort of 35 patients from a tertiary care university hospital. Neuroradiology. 2013;55:379–88.PubMed

67.

Romeike B, Mawrin C. Gliomatosis cerebri: growing evidence for diffuse gliomas with wide invasion. Expert Rev Neurother. 2008;8:587–7.PubMed

68.

Filley CM, Kleinschmidt-DeMasters BK, Lillehei KO, Damek DM, Harris JG. Gliomatosis cerebri: neurobehavioral and neuropathological observations. Cogn Behav Neurol. 2003;16:149–59.PubMed

69.

Galanaud D, Chinot O, Nicoli F, Confort-Gouny S, Le Fur Y, Barrie-Attarian M, et al. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg. 2003;98:269–76.PubMed

70.

Caramanos Z, Narayanan S, Arnold DL (2005) 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. Brain.128:2483–506.PubMed

71.

Commins DL. Pathology of primary central nervous system lymphoma. Neurosurg Focus. 2006;21(5):E2.

72.

Seifried C, Weidauer S, Hinsch N, Bug R, Steinmetz H. Cerebral lymphomatoid granulomatosis. A case report. Nervenarzt. 2007;78:193–7.PubMed

73.

Fauci AS, Haynes BF, Costa J, Katz P, Wolff SM. Lymphomatoid granulomatosis. Prospective clinical and therapeutic experience over 10 years. N Engl J Med. 1982;306:68–74.PubMed

74.

Haldorsen I, Espeland A, Larsson E. Central nervous system lymphoma: Characteristic findings on traditional and advanced imaging. Am J Neuroradiol. 2011;32:984–92.PubMed

75.

Kitajima M, Korogi Y, Shigematsu Y, Matsuoka M, Yamamoto T, Jhono M, et al. Central nervous system lesions in adult T-cell leukaemia: MRI and pathology. Neuroradiology. 2002;44:559–67.PubMed

76.

Martin-Duverneuil N, Mokhtari K, Behin A, Lafitte F, Hoang-Xuan K, Chiras J. Intravascular malignant lymphomatosis. Neuroradiology. 2002;44:749–54.PubMed

77.

Albrecht R, Krebs B, Reusche E, Nagel M, Lencer R, Kretzschmar H. Signs of rapidly progressive dementia in a case of intravascular lymphomatosis. Eur Arch Psychiatry Clin Neurosci. 2005;232:232–5.

78.

Marino D, Sicurelli F, Cerase A, Tripodi S, Cintorino M, Lazzi S, et al. Fulminant intravascular lymphomatosis mimicking acute haemorrhagic leukoencephalopathy. J Neurol Sci. 2012;320:141–4.PubMed

79.

Lai R, Abrey LA, Rosenblum MK, DeAngelis LM. Treatment-induced leukoencephalopathy in primary CNS lymphoma. Neurology. 2004;62:451–6.PubMed

80.

Weidauer S, von Stuckrad-Barre S, Dettmann E, Zanella FE. Cerebral Erdheim-Chester disease: case report and review of the literature. Neuroradiology. 2003;45:241–5.PubMed

81.

Grois N, Prayer D, Prosch H, Lassmann H, and the CNS LCH Co-operative Group. Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain. 2005;128:829–38.

82.

Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.PubMedCentralPubMed

83.

Tintore M, Sastre-Garriga J. Role of MRI criteria and OB for diagnosing multiple sclerosis in patients presenting with clinically isolated syndromes. Mult Scler. 2009;15:407–8.PubMed

84.

Radue EW, DeVera A, Bacelar O, Müller-Lenke N. Interpretation of magnetic resonance imaging in the diagnosis of multiple sclerosis. Clin Neuroradiol. 2004;14:233–44.

85.

Barkhof F, Scheltens P. Is the whole brain periventricular? J Neurol Neurosurg Psychiatry. 2006;77:143–4.PubMedCentralPubMed

86.

Filippi M, Rocca MA, Calabrese M, Sormani MP, Rinaldi F, Perini P, et al. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology. 2010;75:1988–94.PubMed

87.

Oppenheimer DR. The cervical cord in multiple sclerosis. Neuropathol Appl Neurobiol. 1978;4:151–62.PubMed

88.

Bot JC, Barkhof F, Lycklama à Nijeholt G, van Schaardenburg D, Voskuyl AE, Ader HJ, et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology. 2002;223:46–56.PubMed

89.

Montalban X, Tintoré M, Swanton J, Barkhof F, Fazekas F, Filippi M, et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology. 2010;74:427–34.PubMed

90.

Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain. 1999;122:17–26.PubMed

91.

Hu W, Lucchinetti CF. The pathological spectrum of CNS inflammatory demyelinating diseases. Semin Immunpathol. 2009;31:439–53.

92.

Geurts JJ, Stys PK, Minagar A, Amor S, Zivanidov R. Gray matter pathology in (chronic) MS: modern views on an early observation. J Neurol Sci. 2009;282:12–20.PubMed

93.

Geurts JJ, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 2011;76:418–24.PubMed

94.

Seewann A, Kooi EJ, Roosendaal SD, Pouwels PJ, Wattjes MP, van der Valk P, et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012;78:302–8.PubMed

95.

Horowitz AL, Kaplan RD, Grewe D, White RT, Salberg LM. The ovoid lesion: a new MR observation in patients with multiple sclerosis. Am J Neuroradiol 1989;10:303–5.PubMed

96.

Esiri MM, Oppenheimer DR. Diagnostic Neuropathology. Oxford: Blackwell Scientific Publications; 1989.

97.

Swanton JK, Fernando K, Dalton CM, Miszkiel KA, Thompson AJ, Plant GT, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry. 2006;77:830–3.PubMedCentralPubMed

98.

Swanton JK, Rovira A, Tintore M, Altmann DR, Barkhof F, Filippi M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicenter retrospective study. Lancet Neurol. 2007;6:677–86.PubMed

99.

Rocca MA, Agosta F, Sormani MP, Fernando K, Tintorè M, Korteweg T, et al. A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol. 2008;255:683–91.PubMed

100.

Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14:1157–74.PubMedCentralPubMed

101.

Seewann A, Enzinger C, Filippi M, Barkhof F, Rovira A, Gass A, et al. MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain. A review of reported findings. J Neurol. 2008;255:1–10.PubMed

102.

Tallantyre EC, Dixon JE, Donaldson I, Owens T, Morgan PS, Morris PG, et al. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology. 2011;76:534–9.PubMedCentralPubMed

103.

Lanfermann H, Pilatus U, Preibisch C, Hattingen E, Weidauer S, Bink A, et al. 3T in Neuroradiology – battle between request and reality. Clin Neuroradiol 2006;16:91–108.

104.

Haacke EM, Makki M, Ge Y, Maheshwari M, Sehgal V, Hu J, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging. 2009;29:537–44.PubMedCentralPubMed

105.

Hattingen E, Magerkurth J, Pilatus U, Hübers A, Wahl M, Ziemann U. Combined (1)H and (31)P spectroscopy provides new insights into the pathobiochemistry of brain damage in multiple sclerosis. NMR Biomed. 2011;24:536–46.PubMed

106.

Harrison DM, Caffo BS, Shiee N, Farrell JA, Bazin PL, Farrell SK, et al. Longitudinal changes in diffusion tensor-based quantitative MRI in multiple sclerosis. Neurology. 2011;76:179–86.PubMedCentralPubMed

107.

Tintoré M, Rovira A, Río J, Nos C, Grivé E, Sastre-Garriga J, et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology. 2003;60:27–30.PubMed

108.

Nielsen JM, Korteweg T, Barkhof F, Uitdehaag BMJ, Polman CH. Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria. Ann Neurol. 2005;58:781–3.PubMed

109.

Posner CM, Brinar VV. The nature of multiple sclerosis. Clin Neurol Neurosurg. 2004;106:159–71.

110.

Young, NP, Weinshenker BG, Lucchinetti CF. Acute disseminated encephalomyelitis: current understanding and controversies. Semin Neurol. 2008;28:84–94.PubMed

111.

Menge T, Hemmer B, Nessler S, Wiendl H, Neuhaus O, Hartung HP, et al. Acute disseminated encephalomyelitis. An update. Arch Neurol. 2005;62:1673–80.PubMed

112.

Décard BF, Thöne J, Gold R. Differential diagnosis of suspected multiple sclerosis (MS)—MS mimics. Akt Neurol. 2012;39:83–99.

113.

Eckstein C, Saidha S, Levy M. A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis. J Neurol. 2012;259:801–16.PubMed

114.

Brinar VV, Habek M. Rare infections mimicking MS. Clin Neurol Neurosurg. 2010;112:625–8.PubMed

115.

Hildenbrand P, Craven DE, Jones R, Nemeskal P. Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis. AJNR Am J Neuroradiol. 2009;30:1079–89.PubMed

116.

Zarei M. Clinical characteristics of cortical multiple sclerosis. J Neurol Sci. 2006;245:53–8.PubMed

117.

Flanagan EP, Caselli RJ. Autoimmune encephalopathy. Semin Neurol. 2011;31:144–57.PubMed

118.

Chong JY, Rowland LP, Utiger RT. Hashimoto encephalopathy syndrome or myth? Arch Neurol. 2003;60:164–71.PubMed

119.

Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006;63:197–202.PubMed

120.

Grommes C, Griffin C, Downes KA, Lerner AJ. Steroid-responsive encephalopathy associated with autoimmune thyroiditis presenting with diffusion MR imaging changes. AJNR Am J Neuroradiol. 2008;29:1550–1.PubMed

121.

Mahad DJ, Staugaitis S, Ruggieri P, Parisi J, Kleinschmidt–Demasters BK, Lassmann H, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination. J Neurol Sci. 2005;228:3–5.PubMed

122.

Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004;62:1177–82.PubMed

123.

Hadjivassiliou M, Sanders DS, Grünewald RA, Woodroofe N, Boscolo S, Aeschlimann D. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010;9:318–30.PubMed

124.

Kieslich M, Errrazuriz G, Rosselt HG, Moeller-Hartmann W, Zanella F, Boehles H. Brain white matter lesions in celiac disease: a prospective study of 75 diet- treated patients. Pediatrics. 2001;108:E21.

125.

Frings M, Blaeser I, Kastrup O. Adult-onset subacute sclerosing panencephalitis presenting as a degenerative dementia syndrome. J Neurol. 2002;249:942–3.PubMed

126.

Garg RK. Subacute sclerosing panencephalitis. Postgrad Med J. 2002;78:63–70.PubMedCentralPubMed

127.

Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BJ. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805–15.PubMed

128.

Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation. 2011;8:184.PubMedCentralPubMed

129.

Wingerchuk DM, Weinshenker BG. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler. 2012;18:5–10.PubMed

130.

McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, et al. CNS aquaporin-4 autoimmunity in children. Neurology. 2008;71:93–100.PubMed

131.

Kim W, Park MS, Lee SH, Kim S-H, Jung IJ, Takahashi T, et al. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler. 2010;16:1229–36.PubMed

132.

Kim W, Kim SH, Lee SH, Li XF, Kim HJ. Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler. 2011;17:1107–12.PubMed

133.

Bartynsky WS: Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. Am J Neuroradiol. 2008;29:1043–9.

134.

Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S. Cloud-like enhancement“ is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol. 2009;66:425–8.PubMed

135.

Graham JW, Jan W. MRI and the brain in systemic lupus erythematosus. Lupus. 2003;12:891–6.PubMed

136.

Theodoridou A, Settas L. Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry. 2006;77:290–5.PubMedCentralPubMed

137.

Cikes N, Bosnic D, Sentic M. Non-MS autoimmune demyelination. Clin Neurol Neurosurg. 2008;110:905–12.PubMed

138.

Ferreira S, D’Cruz DP, Hughes GRV. Multiple sclerosis, neuropsychiatric lupus and antiphopholipid syndrom: where do we stand? Rheumatology. 2005;44:434–42.PubMed

139.

Pfueller CF, Seipelt E, Zipp F, Paul F. Multiple sclerosis following etanercept treatment for ankylosing spondylitis. Scand J Rheumatol. 2008;37:397–9.PubMed

140.

Gomez-Gallego M, Meca-Lallana J, Fernandez-Barreiro A. Multiple sclerosis onset during Etanercept treatment. Eur Neurol. 2008;59:91–3.PubMed

141.

Sibbitt WL, Brooks WM, Kornfeld M, Hart BL, Bankhurst AD, Roldan CA. Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum. 2010;40:32–52.PubMedCentralPubMed

142.

Jennekens FGI, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology. 2002;41:619–30.PubMed

Title: Differential Diagnosis of White Matter Lesions: Nonvascular Causes—Part II
Authors: S. Weidauer
M. Nichtweiß
E. Hattingen
Publication date: 01-06-2014
Publisher: Springer Berlin Heidelberg
Published in: Clinical Neuroradiology / Issue 2/2014
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI: https://doi.org/10.1007/s00062-013-0267-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Differential Diagnosis of White Matter Lesions: Nonvascular Causes—Part II

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2014

Orbital Masses: the Usefulness of Diffusion-Weighted Imaging in Lesion Categorization

The 49th Annual Meeting of the German Society of Neuroradiology, Cologne, October 23rd to 25th, 2014

Cranial Dural Cavernous Angioma

Prevalence of Incidental Narrowing of the Superior Segment of the Internal Jugular Vein in Patients Without Multiple Sclerosis

Detection of Pulsation in Unruptured Cerebral Aneurysms by ECG-Gated 3D-CT Angiography (4D-CTA) with 320-Row Area Detector CT (ADCT) and Follow-up Evaluation Results: Assessment Based on Heart Rate at the Time of Scanning

Freiburg Neuropathology Case Conference: Multiple Small Ring-Enhancing Lesions in a 75-Year-Old Patient